- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Palvella Therapeutics Inc (PVLA)
Assess today's live Palvella Therapeutics Inc (PVLA) share price, performance and insights using our live NASDAQ: PVLA stock exchange data.
Analyse the historical data and Palvella Therapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on Palvella Therapeutics share price buy/sell indicators using real-time data (or discuss the Palvella Therapeutics (PVLA) stock price today with other investors in the Palvella Therapeutics NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ PVLA share price (ISIN: US6979471090) to enhance your trading decisions with our free investment tools and resources.
What Is the Palvella Therapeutics Inc Share Price Today?
The Palvella Therapeutics share price today is 100.270.
What Is the Stock Symbol for Palvella Therapeutics Inc
The stock symbol (or 'ticker') for Palvella Therapeutics Inc is "PVLA."
What Stock Exchange Does Palvella Therapeutics Inc Trade On?
Palvella Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Palvella Therapeutics Inc a Good Stock to Buy?
Determining whether Palvella Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Palvella Therapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on Palvella Therapeutics share price buy/sell indicators using real-time data (or discuss the Palvella Therapeutics (PVLA) stock price today with other investors in the Palvella Therapeutics NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ PVLA share price (ISIN: US6979471090) to enhance your trading decisions with our free investment tools and resources.
What Is the Palvella Therapeutics Inc Share Price Today?
The Palvella Therapeutics share price today is 100.270.
What Is the Stock Symbol for Palvella Therapeutics Inc
The stock symbol (or 'ticker') for Palvella Therapeutics Inc is "PVLA."
What Stock Exchange Does Palvella Therapeutics Inc Trade On?
Palvella Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Palvella Therapeutics Inc a Good Stock to Buy?
Determining whether Palvella Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
99.000
111.680
52 wk Range
11.170
114.690
PVLA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
99.000111.680
52 wk Range
11.170114.690
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PVLA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
182.571
Upside
+82.08%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral
Palvella Therapeutics Company Profile
Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases. The company's lead product candidate is QTORIN 3.9% rapamycin anhydrous gel that is in Phase 3 clinical trial for the treatment of microcystic lymphatic malformations, as well as in Phase 2 clinical trial to treat cutaneous venous malformations. It also develops QTORIN rapamycin for the treatment of other mTOR-driven skin diseases. The company is based in Wayne, Pennsylvania
Palvella Therapeutics Inc Earnings Call Summary for Q2/2025
- Palvella's stock fell 11.51% to $39.50 in premarket trading despite 272% YTD return, reflecting concerns over financial losses
- Q2 cash position strong at $70.4M, with runway into 2027; operating expenses high at $9.3M; expected to end 2025 with $55M cash
- Phase III CELVA study enrollment exceeded targets with 51 subjects; top-line results expected Q1 2026
- Two new programs focused on Qtorin platform to be announced in H2 2025; Phase II TOYVA study results due Q4 2025
- Future EPS forecasts indicate continued losses; analyst price targets range from $38 to $90 with bullish consensus
Last Updated: 14/08/2025, 14:48
Read Full TranscriptCompare PVLA to Peers and Sector
Metrics to compare | PVLA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPVLAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −36.7x | −2.4x | −0.6x | |
PEG Ratio | 0.25 | 0.09 | 0.00 | |
Price/Book | 30.7x | 4.0x | 2.6x | |
Price / LTM Sales | - | 19.2x | 3.2x | |
Upside (Analyst Target) | 75.1% | 133.4% | 41.8% | |
Fair Value Upside | Unlock | 1.1% | 5.1% | Unlock |
Analyst Ratings
14 Buy
0 Hold
0 Sell
Ratings:
14 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 182.571
(+82.08% Upside)
Earnings
Latest Release
Nov 10, 2025
EPS / Forecast
-1.03 / -2.13
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Palvella Therapeutics (PVLA) Share Price Today?
The live Palvella Therapeutics share price today is 100.270
What Stock Exchange Does Palvella Therapeutics (PVLA) Trade On?
Palvella Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Palvella Therapeutics?
The stock symbol (also called a 'ticker') for Palvella Therapeutics is "PVLA."
What Is the Current Palvella Therapeutics Market Cap?
As of today, Palvella Therapeutics market capitalisation is 1.19B.
What Is Palvella Therapeutics's (PVLA) Earnings Per Share (TTM)?
The Palvella Therapeutics EPS is currently -3.53 (Trailing Twelve Months).
Is PVLA a Buy or Sell From a Technical Analyst Perspective?
Based on today's Palvella Therapeutics moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Palvella Therapeutics Stock Split?
Palvella Therapeutics has split 2 times. (See the PVLA stock split history page for full effective split date and price information.)
How Many Employees Does Palvella Therapeutics Have?
Palvella Therapeutics has 14 employees.
What is the current trading status of Palvella Therapeutics (PVLA)?
As of 24 Dec 2025, Palvella Therapeutics (PVLA) is trading at a price of 100.270, with a previous close of 100.270. The stock has fluctuated within a day range of 99.000 to 111.680, while its 52-week range spans from 11.170 to 114.690.
What Is Palvella Therapeutics (PVLA) Price Target According to Analysts?
The average 12-month price target for Palvella Therapeutics is USD182.57143, with a high estimate of USD212 and a low estimate of USD133. 14 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +82.08% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.